Valerie Barber Palmieri
Net Worth

Last updated:

What is Valerie Barber Palmieri net worth?

The estimated net worth of Ms. Valerie Barber Palmieri is at least $6,629,381 as of 16 May 2022. She owns shares worth $21,901 as insider and has received compensation worth at least $6,607,480 in Aspira Women's Health Inc..

What is the salary of Valerie Barber Palmieri?

Ms. Valerie Barber Palmieri salary is $600,680 per year as Chief Executive Officer, Pres & Director in Aspira Women's Health Inc..

How old is Valerie Barber Palmieri?

Ms. Valerie Barber Palmieri is 64 years old, born in 1961.

What stocks does Valerie Barber Palmieri currently own?

As insider, Ms. Valerie Barber Palmieri owns shares in one company:

Company Title Shares Price per share Total value
Aspira Women's Health Inc. (AWH) Chief Executive Officer, Pres & Director 267,088 $0.08 $21,901

What does Aspira Women's Health Inc. do?

Aspira Women's Health Inc., together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. The company provides OVA1, OVERA, and OVA1plus to detect risk of ovarian malignancy in women with adnexal masses. It also offers ASPiRA GenetiX, a genetic test for the risk of gynecologic cancer. In addition, the company operates Aspira Synergy, a testing platform and cloud service for decentralized access of protein biomarker and hereditary genetic testing; and owns and operates ASPiRA LABS, a lab that specializes in applying biomarker-based technologies to address critical needs in the management of gynecologic cancers and disease. Further, its pipeline products include OVAWatch, EndoCheck, and OVAInherit. The company serves physicians, physician office laboratories, and national and regional laboratories. It has a collaborative research agreement with Baylor Genetics; an agreement with Harvard Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Medical University Lodz to evaluate the microRNA technology in combination with Aspira technologies for the development of an early detection test for ovarian cancer; and a strategic alliance with Quest Diagnostics, Incorporated. The company was formerly known as Vermillion, Inc. and changed its name to Aspira Women's Health Inc. in June 2020. Aspira Women's Health Inc. was incorporated in 1993 and is headquartered in Austin, Texas.

Valerie Barber Palmieri insider trading

Aspira Women's Health Inc.

Transaction Date Security Shares Price per share Total value Source
Purchase
Common Stock 43,994 $0.57 $24,901
Purchase
Common Stock, par value $0.001 per share 37,500 $0.8 $30,000
Purchase
Common Stock, par value $0.001 per share 97,000 $0.52 $50,440
Purchase
Common Stock, par value $0.001 per share 19,100 $0.51 $9,741
Purchase
Common Stock, par value $0.001 685 $1.46 $1,000
Purchase
Common Stock, par value $0.001 694 $1.44 $999
Purchase
Common Stock, par value $0.001 719 $1.39 $999
Purchase
Common Stock, par value $0.001 768 $1.3 $998
Purchase
Common Stock, par value $0.001 555 $1.8 $999
Purchase
Common Stock, par value $0.001 10,042 $1.4 $14,059
Purchase
Warrants (Right to buy) 7,531 $1.8 $13,556
Purchase
Common Stock 3,500 $1.51 $5,285
Purchase
Common Stock 15,000 $1.38 $20,700
Purchase
Common Stock 15,000 $1.38 $20,700

Aspira Women's Health key executives

Aspira Women's Health Inc. executives and other stock owners filed with the SEC: